The NTIS website and supporting ordering systems are undergoing a major upgrade from 8PM on September 25th through approximately October 6. During that time, much of the functionality, including subscription and product ordering, shipping, etc., will not be available. You may call NTIS at 1-800-553-6847 or (703) 605-6000 to place an order but you should expect delayed shipment. Please do NOT include credit card numbers in any email you might send NTIS.
Documents in the NTIS Technical Reports collection are the results of federally funded research. They are directly submitted to or collected by NTIS from Federal agencies for permanent accessibility to industry, academia and the public.  Before purchasing from NTIS, you may want to check for free access from (1) the issuing organization's website; (2) the U.S. Government Printing Office's Federal Digital System website; (3) the federal government Internet portal; or (4) a web search conducted using a commercial search engine such as
Accession Number ADA567356
Title Breast Cancer Diagnostics Based on Spatial Genome Organization.
Publication Date Jul 2012
Media Count 19p
Personal Author K. Meaburn T. Misteli
Abstract Genomes are non-randomly organized within the cell nucleus. Importantly, individual gene loci undergo changes to their spatial position during disease, including cancer. We exploited, for the first time, these changes in spatial gene positioning as a novel tool for the detection of invasive breast cancer. Repositioning events in cancer cells are not a reflection of a global spatial genome reorganization and are instead gene- specific. Out of 20 genes we examined, 8 occupied significantly different intra- nuclear positions in breast cancer compared to normal tissues. Such genes serve as Gene Positioning Biomarkers (GPBs). We have demonstrated that these GPBs can accurately distinguish normal from cancer tissues. Crucially for a diagnostic test, these repositioning events were specific to cancer. There is little variation in the spatial positioning patterns of genes amongst normal individuals and most genes did not reposition in the benign breast diseases hyperplasia and fibroadenoma. We also adapted the approach to the requirements in a clinical setting by developing a normalized standard reference distribution for all GPB genes and by demonstrating that multiplexed combinatorial gene markers can further improve sensitivity and specificity. Our observations provide the first proof-of-principle that the spatial positioning of the genome can be used for diagnostic applications.
Keywords Breast cancer
Clinical medicine
Mammary glands

Source Agency Non Paid ADAS
NTIS Subject Category 57A - Anatomy
57S - Physiology
57E - Clinical Medicine
Corporate Author The Geneva Foundation, Tacoma, WA.
Document Type Technical report
Title Note Final rept. 1 Sep 2008-30 Jun 2012.
NTIS Issue Number 1309
Contract Number W81XWH-08-2-0098

Science and Technology Highlights

See a sampling of the latest scientific, technical and engineering information from NTIS in the NTIS Technical Reports Newsletter

Acrobat Reader Mobile    Acrobat Reader